Registry for advanced sarcoidosis (ReAS) - ReAS

Sint Antonius Ziekenhuis0 个研究点目标入组 100 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

暂无简介。

•* Patients with diagnosis of sarcoidosis based on ATS/WASOG criteria 22
•* Age * 18 years.
•* Life expectancy of at least 2 years.
•* Pulmonary function tests (spirometry) within one month of entry or willing to under pulmonary
•function testing on the day of study enrollment
•* Sarcoidosis as characterized as either advanced or non-advanced (see protocol for definition
•of advanced disease)
•* Subjects must be able to understand and be willing to sign the written informed consent
•form. A signed informed consent form must be appropriately obtained prior to the conduct of
•any trial-specific procedure.

•* Subjects with a medical disorder, condition, or history of such that would impair the subject*s
•ability to participate or complete this study in the opinion of the investigator
•* Inability to comply with the protocol and/or not willing or not available for follow-up
•assessments.

发起方